In the News

An eye-based Alzheimer’s disease test Routine eye exams could provide data to identify a patient’s disease risk earlier Spotted: Dementia diagnoses appear to be increasing worldwide, most likely from a combination of ageing populations and improved awareness of the disease alongside strengthened diagnostic tools. In Canada, medical AI company RetiSpec uses commonly used eye exam images to diagnose Alzheimer’s […]

NEWS PROVIDED BYiLoF , Jul 31, 2024, 09:28 ET The international clinical study, Bio-Hermes-002, establishes an ambitious transnational collaboration aimed at achieving a breakthrough in Alzheimer’s diagnosis and treatment. LONDON and ROCHESTER, N.Y., July 31, 2024 /PRNewswire/ — iLoF, a global deep tech digital health company, today announced it has secured a £1.2M (~$1.5M) clinical research contract from Innovate UK, […]

In this free webinar, learn how blood biomarkers can help identify amyloid plaques, a diagnostic hallmark of Alzheimer’s disease through the Bio-Hermes study. The featured speakers will discuss the impact of this study for those living with the disease as well as physicians and researchers. Attendees will also gain insights into improving Alzheimer’s disease diagnoses […]

By Jordan Bowen, Published  July 29, 2024 10:22pm EDT Could a blood test help diagnose Alzheimer’s? A study published in the Journal of the American Medical Association found a specific blood test known as the p-tau217 can determine if someone’s memory loss issues are caused by Alzheimer’s disease. TAMPA, Fla. – It’s a fear many of us have […]

Funded by a nearly £1.2M (~$1.5M USD) award, this research will enable ongoing validation of AccelADx™, a breakthrough screening test for early detection of Alzheimer’s dementia. BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 11, 2024 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through […]

Cambridge, UK—10 July 2024: Cambridge Cognition, a leading provider of digital health solutions for brain health assessments has been included in the Bio-Hermes 2 project for its voice and touch-screen cognitive assessments, funded by the UK’s innovation agency, Innovate UK.  The Bio-Hermes 2 trial, led by the Global Alzheimer’s Platform Foundation (GAP), aims to determine […]

10 July 2024 Innovate UK has awarded four UK companies a share of £4 million funding through Contracts for Innovation to support innovative research into dementia diagnosis. The funding will enable organisations to evaluate blood-based and digital biomarkers as part of the Bio-Hermes-002 study. This international study is led by the Global Alzheimer’s Platform Foundation® […]

The Washington, D.C.-based Global Alzheimer’s Platform Foundation announced on July 8 that Snellville resident Tamiko MaGee-Rodgers has been named director of the foundation’s Recruitment and Strategic Initiatives. The nonprofit GAP was founded to speed the delivery of Alzheimer’s treatments with a commitment to promoting diversity in clinical research and lowering the cost and duration of […]

Resident contributor, Dr. Susan Steen breaks down three life changes to trackto prioritize your brain health as you and your loved ones age. As people age, it’s normal to experience occasional forgetfulness, however when does ‘some’ memory loss become a bigger concern? There are three aspects of your life that you can reflect on and […]

Global Alzheimer’s Platform Foundation 2023 National Citizen Scientist Champion Award recipient Jeannie Weiss and Syrentis Clinical Research Vice President/Director of Clinical Operations Dr. Lorrie Bisesi join to discuss Alzheimer’s #octalkradio

May 23, 2024 at 02:00 am EDT IXICO plc announced that it has signed a contract with the Global Alzheimer’s Platform Foundation (GAP) to support GAP’s planned Bio-Hermes 2 trial. The contract value is worth over £1 million over a 48-month term. The Company does not expect to adjust its expectations of performance for the […]

In the hands of the SFC-funded Brain Health ARC, the Bio-Hermes dataset offers the Scottish dementia research community a platform for new ideas, collaboration and early career development. Millie Mather explains more in our latest guest blog. During my working hours, I can be identified as the sole person in the room without a PhD in science or medicine. In fact, […]

Syrentis Clinical Research will hold a free memory screening event on Thursday, May 16, for people aged 50 and above to increase awareness for early detection of memory loss and Alzheimer’s disease. In California, it is estimated that more than 690,000 people are currently living with Alzheimer’s Disease, and experts predict that this number will […]

By:OCI Staff Syrentis Clinical Research will hold a free memory screening event on Thursday, May 16 for people aged 50 and above to increase awareness for early detection of memory loss and Alzheimer’s disease. In California, it is estimated that more than 690,000 people are currently living with Alzheimer’s Disease, and experts predict that this […]

By  Community News Releases, May 9, 2024 Visionary Investigators Network honored Joanne Bridges, the recipient of the 2023 National Citizen Scientist Collaborator Award® to recognize her extraordinary efforts as a study partner in an Alzheimer’s clinical trial at  Visionary Investigators Network. The Aventura mother and resident was selected as a National Honoree for the Global Alzheimer’s Platform Foundation® (GAP) Collaborator Award, from a […]

BY CAIT MCVEY TAMPA | Spectrum News 1 TAMPA, Fla. — Research included in a new report by the Alzheimer’s Association shows Black Americans are twice as likely to have Alzheimer’s disease than white Americans, yet the population is significantly underrepresented in clinical trials for treatments. It’s a statistic Dr. Susan Steen, president of Axiom Clinical Research of Florida, said […]

by Cathy Kelly, April 15, 2025 The agency’s projection that Medicare will spend $3.5bn on Leqembi in 2025 is nearly three times the level of sales that marketer Eisai is expecting for the drug in North and South America combined in its fiscal year 2026. The Centers for Medicare and Medicaid Services appear to be […]

trialsitenews Staff at TrialSite | Quality Journalism Apr. 12, 2024, 1:00 p.m. Expensive and not always covered by insurance, the standard most reliable method of diagnosing Alzheimer’s disease is via positron emission tomography or PET scan of the brain. Another more cumbersome, invasive and painful approach is the spinal tap. What if there was an […]

Costa Mesa resident Jeannie Weiss is driving Alzheimer’s research forward and is receiving a national award for her exemplary volunteerism to help advance science. The Global Alzheimer’s Platform Foundation (GAP) recognized Weiss for her exceptional role in Alzheimer’s research. Weiss received GAP’s 2023 National Citizen Scientist Champion Award, which is given to individuals who act […]

Purchase of Axiom Brain Health puts Tampa clinical trial site at center of research to find easier way to detect disease in patients. TAMPA — The most reliable way to to diagnose Alzheimer’s disease is through a positron emission tomography or PET scan of the brain, an expensive test not always covered by insurance. Another […]

28th March 2024 Scotland has been selected to host a first-of-its-kind Alzheimer’s research competition, representing ‘significant recognition of the country’s wealth of world-leading expertise,’ says the Chief Scientist for Health Professor Anna Dominiczak welcomed the news that Scotland has already launched the Bio-Hermes Biomarker Data Challenge, granting access to what has been called “the most comprehensive […]

The Global Alzheimer’s Platform Foundation® (GAP) has announced that Scotland will host the Bio-Hermes Biomarker Data Challenge 2024, a groundbreaking research competition utilizing the most extensive collection of dementia biomarker data from innovative early blood testing studies for Alzheimer’s disease. Researchers at the Universities of Glasgow and St. Andrews, under the auspices of the Scottish […]

POSTED ON MARCH 19, 2024BY CHRIS YOUNG It’s estimated over 580 thousand Floridians are living with Alzheimer’s disease. A study could lead to a simpler way to detect the disease. The study, called Bio-Hermes, showed how new Alzheimer’s detecting blood tests perform across a broad range of races and ethnicities for the first time. Currently, scans or spinal taps […]

By Editor,  MAR 16, 2024 WASHINGTON, DC (Feb. 19, 2024) — Today, the Global Alzheimer’s Platform Foundation (GAP) recognized Orange County resident Jeannie Weiss for her exceptional role in Alzheimer’s research. Jeannie Weiss received GAP’s 2023 National Citizen Scientist Champion Award®, which is given to individuals who act as a stimulus in bringing new, novel approaches to Alzheimer’s research […]